The wrist has become the most data-rich interface between the human body and the digital healthcare system. A smartwatch worn by a 60-year-old in 2025 continuously measures heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiratory rate, skin temperature, sleep architecture (REM/deep/light stages), activity, and electrodermal activity (EDA, a stress proxy). It can take a medical-grade 30-lead equivalent single-lead ECG on demand. It can detect atrial fibrillation with 98.5% specificity. And it can alert both the wearer and their cardiologist if it does.
The Cardiology Transformation
The Apple Watch's FDA-cleared AFib detection has arguably had greater population-level cardiovascular impact than any single pharmaceutical introduced in the past decade. The Apple Heart Study (419,093 participants, Stanford/Apple, 2019) demonstrated that wearable continuous photoplethysmography (PPG) can detect AFib with high sensitivity in undiagnosed patients. Follow-up analysis suggests that Apple Watch-detected AFib prompts anticoagulation in tens of thousands of patients annually who would otherwise remain undiagnosed and at high stroke risk.
Beyond AFib, wearable ECG patches including the Zio Patch (iRhythm) — worn for up to 14 days — have replaced 24-hour Holter monitors for arrhythmia evaluation, detecting arrhythmias missed by short-duration monitoring with 40% higher yield. The AliveCor KardiaMobile 6L captures a six-lead ECG using electrode-equipped smartphone cases, bringing clinical-quality cardiac monitoring to primary care and home settings.
Non-Invasive Blood Pressure Monitoring
Ambulatory blood pressure monitoring (ABPM) has long been the gold standard for hypertension diagnosis, but 24-hour cuff-based monitors are uncomfortable and disruptive. Multiple wearable approaches to cuff-free continuous blood pressure monitoring are advancing:
- Samsung Galaxy Watch BP monitoring (cleared in South Korea, Europe): uses PPG pulse wave transit time algorithms calibrated against periodic cuff measurements.
- Valencell continuous BP sensor: ear-worn continuous monitoring achieving ±3 mmHg accuracy in clinical validation.
- OMRON HeartGuide: wristwatch-oscillometric BP monitor achieving American Heart Association validation criteria.
True cuff-free, calibration-free continuous BP monitoring at clinical accuracy remains the most sought-after wearable measurement — estimated to be a $10B+ market once validated.
Sweat Biomarker Sensing
The next frontier is epidermal electrochemical sensing — flexible patch sensors applied to skin that analyze sweat composition in real time. Sweat contains sodium, potassium, lactate, glucose, uric acid, cortisol, and cytokines, each providing real-time windows into metabolic, stress, and inflammatory status that blood tests capture only episodically.
The Gatorade Gx Sweat Patch (consumer), NUVITA biosensor (clinical), and research platforms from UC Berkeley (Professor Ali Javey's group) and Northwestern (Professor John Rogers) are establishing the technology foundation. Enzymatic glucose sensors integrated into wearable patches achieved ±18% MARD in interstitial fluid in 2024 validation studies — approaching but not yet matching clinical CGM accuracy. Clinical-grade wearable sweat glucose monitoring is expected within 2–3 years.
Implantable Sensors: The Next Tier
For chronic disease management requiring continuous precision monitoring, implantable sensors offer advantages over skin-worn devices: no signal variability from motion or ambient interference, no daily recharging, and access to blood-phase rather than interstitial-phase measurements. The Sensata SensiumVitals thoracic implant monitors heart rate, respiratory rate, and temperature continuously in cardiac patients. Medtronic's Linq II insertable cardiac monitor records cardiac rhythm for up to 4.5 years on a device the size of a paper clip. The Dexcom G7's shift to ever-smaller sensor profiles and the development of fully implantable glucose monitors (Abbott's Eversense 365 — one year wear, FDA-cleared) represent the implantable frontier of the CGM category.
Healthcare System Integration
The data generated by patient-worn devices creates both opportunity and complexity for healthcare systems. Electronic health record (EHR) integration of wearable data streams is nascent but advancing — Apple Health Records and Fitbit Health Solutions both offer EHR API integrations adopted by forward-looking health systems. The clinical workflow challenge — who reviews 24/7 wearable data streams, what thresholds trigger alerts, and how alert fatigue is managed — is as significant as the technology development itself.
For healthcare supply procurement, wearable health technology creates demand for compatible charging infrastructure in hospital rooms, disposable adhesive ECG patches and PPG sensors, and the clinical peripheral equipment (examination equipment, diagnostic tools) needed to follow up on wearable-detected findings at scale. Healthcare facilities can find relevant diagnostic equipment in our catalog.
